InvestorsHub Logo
Followers 48
Posts 3935
Boards Moderated 0
Alias Born 01/26/2011

Re: md1225 post# 196534

Monday, 11/10/2014 4:11:56 PM

Monday, November 10, 2014 4:11:56 PM

Post# of 346172
Maybe years, MD...

June 27, 2013
Peregrine Pharmaceuticals Provides Update on Bavituximab Clinical Program

Company Strengthens Cash Position as It Prepares to Initiate Phase III Trial in Second-Line NSCLC by Year-End While Partnering Discussions Continue;

This must be some kind of difficult partnership discussion considering it's lasted several years already.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News